Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02389075 · ClinicalTrials.gov registry record
The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
A clinical trial of Ankylosing Spondylitis (AS) and Inflammatory Bowel Diseases (IBD), sponsored by University of Colorado, Denver.
- Active
- Registry status
- 129
- Enrollment target
- 1
- Study location
NCT02389075: Active study of Ankylosing Spondylitis (AS) and Inflammatory Bowel Diseases (IBD), sponsored by University of Colorado, Denver.
NCT02389075 is a study of Ankylosing Spondylitis (AS) and Inflammatory Bowel Diseases (IBD) that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 129 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02389075, a study of Ankylosing Spondylitis (AS) and Inflammatory Bowel Diseases (IBD), is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- 129 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to learn more about the relationship between systemic autoimmune disease, such as inflammatory bowel disease and ankylosing spondyloarthritis, bacteria in the colon, and the changes in colon tissue.
Primary Outcome
The primary goal for this measure will be to demonstrate characteristics of IEL (intraepithelial lymphocytes) subtypes of healthy individuals and compare those with AS or IBD. IEL characteristics will be based on cell marker outcomes using flow cytometry for CD3, CD4, CD8α, CD8β, CD44, CD45, CD62L, CD69, CD103, TCRαβ, and TCRγδ.
Conditions Studied
Interventions
- PROCEDURE Pinch biopsies
- PROCEDURE Flexible sigmoidoscopy
Study Locations (1)
Colorado
- University of Colorado - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2015-03 |
| Est. Completion | 2026-10 |
What the registry record for NCT02389075 still lists
NCT02389075 is an observational study that tracks outcomes without assigning an intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Ankylosing Spondylitis (AS) appearing as the primary indexed condition, and to 2 interventions - of which Pinch biopsies is the first listed.
NCT02389075 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02389075 about?
NCT02389075 is a clinical study titled "The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis". This study plans to learn more about the relationship between systemic autoimmune disease, such as inflammatory bowel disease and ankylosing spondyloarthritis, bacteria in the colon, and the changes in colon tissue.
What is the current status of trial NCT02389075?
This trial is currently active not recruiting. The enrollment target is 129 participants. The study started on 2015-03. Estimated completion is 2026-10.
What conditions does trial NCT02389075 study?
This clinical trial studies the following conditions: Ankylosing Spondylitis (AS), Inflammatory Bowel Diseases (IBD).
What interventions are being tested in trial NCT02389075?
The interventions under investigation include: Pinch biopsies (PROCEDURE), Flexible sigmoidoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02389075?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02389075 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ankylosing Spondylitis (AS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia